Multiple Sclerosis Trial, Recruiting NCT07615725 Sponsor: University of South Florida Condition: Multiple Sclerosis
Back to Multiple Sclerosis

Multiple Sclerosis Trial, Recruiting

NCT07615725
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with Multiple Sclerosis (MS) using a standard set of diagnostic guidelines known as McDonald's Criteria
  • People whose MS-related mobility falls within a certain range on a standard scale called the Patient Determined Disease Steps (PDDS), with a score of 1 to 5, meaning they are still able to walk
  • People who are able to read, write, and speak English
  • People aged between 18 and 80 years old
  • People who have been experiencing pain in one or both legs for at least three months in a row, rated at 3 or more out of 10 on a pain scale

Who may not be able to join:

  • People who have another neurological condition alongside MS, such as a history of stroke or Parkinson's disease
  • People who have had an MS relapse (a flare-up of symptoms) within the last 30 days
  • People who are currently taking part in, or planning to start, any other pain treatment or rehabilitation program targeting the legs during the study period
  • People whose pain medication is expected to change during the study period
  • People who are pregnant (a urine test will be used to check)
  • People who have any active cancer, or who have received chemotherapy within the past year
  • People who score below 17 on a standard memory and thinking assessment called the MoCA (Montreal Cognitive Assessment)
  • People who have a known or suspected infection in the leg or foot area
  • People who have deep vein thrombosis (a blood clot in a deep vein), thrombophlebitis (inflammation of a vein due to a clot), or active bone infection (osteomyelitis) in the lower limb
  • People who have varicose veins in the legs
  • People who have seizures or epilepsy that is not well controlled

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 14 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 8139747193

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of South Florida
Registry
ClinicalTrials.gov
Start date
8 May 2026
Est. completion
1 May 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Pain PROMIS

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov